IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $65,527,063 | +172.7% | 1,665,660 | +68.7% | 0.01% | +250.0% |
Q1 2023 | $24,027,213 | +119.9% | 987,555 | +93.5% | 0.00% | +100.0% |
Q4 2022 | $10,928,520 | +62.5% | 510,440 | +36.2% | 0.00% | 0.0% |
Q3 2022 | $6,724,000 | +152.8% | 374,844 | +35.6% | 0.00% | – |
Q2 2022 | $2,660,000 | -58.5% | 276,444 | -27.5% | 0.00% | -100.0% |
Q1 2022 | $6,414,000 | +111.7% | 381,159 | +110.3% | 0.00% | – |
Q4 2021 | $3,030,000 | +571.8% | 181,238 | +551.5% | 0.00% | – |
Q3 2021 | $451,000 | +19.3% | 27,817 | -53.6% | 0.00% | – |
Q2 2021 | $378,000 | -28.0% | 59,931 | -29.4% | 0.00% | – |
Q1 2021 | $525,000 | +87.5% | 84,926 | +109.8% | 0.00% | – |
Q4 2020 | $280,000 | +55.6% | 40,479 | +27.6% | 0.00% | – |
Q3 2020 | $180,000 | -7.2% | 31,726 | -16.2% | 0.00% | – |
Q2 2020 | $194,000 | +44.8% | 37,870 | -3.4% | 0.00% | – |
Q1 2020 | $134,000 | +2580.0% | 39,202 | +7106.2% | 0.00% | – |
Q4 2019 | $5,000 | -16.7% | 544 | -89.7% | 0.00% | – |
Q3 2019 | $6,000 | +500.0% | 5,285 | +871.5% | 0.00% | – |
Q2 2019 | $1,000 | – | 544 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |